Pathologic Targets in Rheumatoid Arthritis: Modifying the Immune Response to Optimize Patient Outcomes

View Activity
Order 3D Glasses


Jon T. Giles, MD, MPH
Associate Professor of Medicine
Division of Rheumatology
Columbia University
College of Physicians and Surgeons
New York, NY

Gregg J. Silverman, MD
Professor of Medicine and Pathology
Director, Laboratory of B cell Immunobiology
NYU School of Medicine
New York, NY


This online activity is focused on the care of patients with rheumatoid arthritis.


This activity is designed to meet the educational needs of rheumatologists, nurses and allied healthcare professionals involved in the care of patients with rheumatoid arthritis


Upon completion of the program, learners should be better able to:

  • Describe the treatment combinations for patient with moderate-to-severe RA after MTX failure or intolerance
  • Integrate clinical trials data of targeted therapy into the treatment of patients with moderate-to-severe RA
  • Discuss the pathogenesis and risk of cardiovascular disease in patients with RA and the co-management of both conditions
  • Review strategies to optimize patient outcomes through their participation in the RA care plan


Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.


Med Learning Group designates this enduring activity for a maximum of 1.0 AMA Category 1 credit(s)TM.


Purpose: This program would be beneficial for nurses involved in the care of patients with rheumatoid arthritis. Credits: 1.0 ANCC Contact Hours.


Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Complete Conference Management will accredit this educational activity for 1.0 contact hours.


In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG‐sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.


Jon Giles, MD, MPH, serves as a consultant for Roche/Genentech and Lilly. He has received support from NIH/NIAMS, American College of Rheumatology Research and Education Foundation, Arthritis Foundation, Arthritis National Research Foundation, and Pfizer. He is on the DSMB for Coherus.
Gregg Silverman, MD, serves as a consultant for Genentech, Eli Lilly, BMS, and Roche and is on the speaker board for Genentech and Bristol Myers Squibb. He has received support from the Arthritis Foundation, Lupus Research Institute, Rheumatology Research Foundation, and NIH. He is a consultant for Regeneron. A family member is employed by Gilead.
CME content review
The content of this activity was independently peer reviewed. The reviewer of this activity has nothing to disclose.
CNE Content Review
UMA/CCM nurse Reviewer, has nothing to disclose.
The staff, planners, and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:
Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
Ana Maria Albino, Program Manager for Med Learning Group, has nothing to disclose.
Flavia Piazza, PhD, VP Medical and Scientific Services for Med Learning Group, has nothing to disclose.
Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.


Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
During the course of this lecture, the faculty may mention the use of medications for both FDA‐approved and non‐ approved indications.

There are no fees for participating and receiving CME credit for this online activity. To receive CME/CNE credit participants must:

1. Read the CME/CNE information and faculty disclosures;
2. Participate in the enduring activity;
3. Complete pre-and-post surveys; and
4. Submit the evaluation form to the Med Learning Group.

You will receive your certificate via email within 30 days.


Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment,
knowledge, experience, and diagnostic decision‐making before applying any information, whether provided here or by others, for any professional use.

For questions about this activity, please contact: Med Learning Group at

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at:

RELEASE DATE: January 31, 2018

EXPIRATION DATE: January 31, 2019

Order 3D Glasses

View Activity

Participation Statement
This educational activity provides training necessary for licensed attendees to maintain state licensing requirements. The tuition for this educational activity is subsidized in part by unrestricted educational grants, including for those attendees who have successfully completed the state licensing requirements for their respective fields. This subsidy is reflected in the registration fees for this activity.

Copyright © 2018 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.